Brazil vs Ethiopia: HIV/AIDS deaths averted by antiretroviral therapy
Brazil
49,655 deaths
in 2024
Ethiopia
27,746 deaths
in 2024
Brazil rank
10th
Ethiopia rank
13th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Brazil
- Ethiopia
How they compare
Brazil currently reports 49,655 deaths against 27,746 deaths in Ethiopia, a difference of 21,909 deaths.
That makes Brazil's figure about 1.8 times Ethiopia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Ethiopia ahead.
Brazil ranks 10th and Ethiopia ranks 13th of 157 countries.
Across the 4 decades both report, Brazil averaged higher in 3 and Ethiopia in 1.
Head to head by decade
| Decade | Brazil | Ethiopia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4,547 deaths | 0 deaths | 4,547 deaths | Brazil |
| 2000s | 15,777 deaths | 9,193 deaths | 6,584 deaths | Brazil |
| 2010s | 28,138 deaths | 33,113 deaths | 4,975 deaths | Ethiopia |
| 2020s | 47,798 deaths | 29,478 deaths | 18,321 deaths | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Brazil or Ethiopia?
- Brazil, at 49,655 deaths against 27,746 deaths in Ethiopia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Brazil and Ethiopia?
- 21,909 deaths, with Brazil ahead.
- How many years of comparable data are there for Brazil and Ethiopia?
- 35 years are reported by both, from 1990 to 2024.
- How do Brazil and Ethiopia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Brazil ranks 10th and Ethiopia ranks 13th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.